No Data
Is the CRO Concept "Return of the King"? WuXi AppTec aggressively attacks, leading stocks celebrate after performance!
Release the signal?!
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Joinn Laboratories (06127.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui announced on March 14 that Joinn Laboratories (06127.HK) will hold a Board of Directors meeting on March 28, 2025 (Friday) to review and approve the group's annual performance for the year ending December 31, 2024, consider recommending a final dividend (if any), and address other matters.
JOINN Laboratories Schedules Board Meeting to Review Annual Results
JOINN: DATE OF BOARD MEETING
Hong Kong stock movement | Joinn Laboratories (06127) rose over 7% in the final hours as the potential of AI in pharmaceuticals is released, likely empowering the company's non-clinical research on drugs.
Joinn Laboratories (06127) surged over 7% in the late trading session, up 6.7% as of the time of writing, trading at 14.98 Hong Kong dollars, with a transaction amount of 33.8677 million Hong Kong dollars.
Earnings Working Against Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) Share Price
